CHIT1 and tropical spastic paraparesis: Moreover, HAM/TSP patients with rapid disease progression also had higher CHIT1 CSF levels compared to those with typical progression (1.35 ng/mL, IQR 0.96-2.28 ng/mL) (Dunn’s test p = 0.0284) (Figure 2E).